Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria

References

• Anderson, P. J., & Leuzzi, V. (2010). White matter pathology in phenylketonuria. Molecular Genetics and Metabolism, 99, S3–S9. doi:10.1016/j.ymgme.2009.10.005
   PubMed Web of Science ®Google Scholar
• Anjema, K., van Rijn, M., Verkerk, P. H., Burgerhof, J. G. M., Heiner-Fokkema, M. R., & van Spronsen, F. J. (2011). PKU: High plasma phenylalanine concentrations are associated with increased prevalence of mood swings. Molecular Genetics and Metabolism, 104(3), 231–234. doi:10.1016/j.ymgme.2011.05.017
   PubMed Web of Science ®Google Scholar
• Antenor-Dorsey, J. A. V., Hershey, T., Rutlin, J., Shimony, J. S., McKinstry, R. C., Grange, D. K., … White, D. A. (2013). White matter integrity and executive abilities in individuals with phenylketonuria. Molecular Genetics and Metabolism, 109(2), 125–131. doi:10.1016/j.ymgme.2013.03.020
   PubMed Web of Science ®Google Scholar
• Berry, S. A., Brown, C., Grant, M., Greene, C. L., Jurecki, E., Koch, J., … Cederbaum, S. (2013). Newborn screening 50 years later: Access issues faced by adults with PKU. Genetics in Medicine, 15(8), 591–599. doi:10.1038/gim.2013.10
   PubMed Web of Science ®Google Scholar
• Bik-Multanowski, M., Didycz, B., Mozrzymas, R., Nowacka, M., Kaluzny, L., Cichy, W., … Milanowski, A. (2008). Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. Journal of Inherited Metabolic Disease, 31(S2), 415–418. doi:10.1007/s10545-008-0978-7
   Web of Science ®Google Scholar
• Bik-Multanowski, M., & Pietrzyk, J. (2011). [Use of computerized neuropsychological tests and of nuclear magnetic resonance spectroscopy in clinical assessment of adult patients with phenylketonuria]. Przeglad Lekarski, 68(3), 127–131.
   PubMedGoogle Scholar
• Bik-Multanowski, M., Pietrzyk, J. J., & Mozrzymas, R. (2011). Routine use of CANTAB system for detection of neuropsychological deficits in patients with PKU. Molecular Genetics and Metabolism, 102(2), 210–213. doi:10.1016/j.ymgme.2010.10.003
   PubMed Web of Science ®Google Scholar
• Brahmbhatt, S. B., White, D. A., & Barch, D. M. (2010). Developmental differences in sustained and transient activity underlying working memory. Brain Research, 1354, 140–151. doi:10.1016/j.brainres.2010.07.055
   PubMed Web of Science ®Google Scholar
• Brown, C. S., & Lichter-Konecki, U. (2016). Phenylketonuria (PKU): A problem solved? Molecular Genetics and Metabolism Reports, 6, 8–12. doi:10.1016/j.ymgmr.2015.12.004
   PubMed Web of Science ®Google Scholar
• Brown, M. C. J., & Guest, J. F. (1999). Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria. Journal of Intellectual Disability Research, 43(1), 30–37. doi:10.1046/j.1365-2788.1999.43120176.x
   PubMed Web of Science ®Google Scholar
• Brumm, V. L., Azen, C., Moats, R. A., Stern, A. M., Broomand, C., Nelson, M. D., & Koch, R. (2004). Neuropsychological outcome of subjects participating in the PKU adult collaborative study: A preliminary review. Journal of Inherited Metabolic Disease, 27(5), 549–566. doi:10.1023/b:boli.0000042985.02049.ff
   PubMed Web of Science ®Google Scholar
• Burgard, P., Rey, F., Rupp, A., Abadie, V., & Rey, J. (1997). Neuropsychologic functions of early treated patients with Phenylketonuria, on and off diet: Results of a cross-national and cross-sectional study. Pediatric Research, 41(3), 368–374. doi:10.1203/00006450-199703000-00011
   PubMed Web of Science ®Google Scholar
• Burlina, A. B., Bonafé, L., Ferrari, V., Suppiej, A., & Zacchello, F. (2000). Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. Journal of Inherited Metabolic Disease, 23(4), 313–316. doi:10.1023/a:1005694122277
   PubMed Web of Science ®Google Scholar
• Camp, K. M., Parisi, M. A., Acosta, P. B., Berry, G. T., Bilder, D. A., Blau, N., … Young, J. M. (2014). Phenylketonuria scientific review conference: State of the science and future research needs. Molecular Genetics and Metabolism, 112(2), 87–122. doi:10.1016/j.ymgme.2014.02.013
   PubMed Web of Science ®Google Scholar
• Campistol, J., González, M. J., Gutiérrez, A. P., & Vilaseca, M. A. (2012). Tratamiento y control de los pacientes con fenilcetonuria: Resultados del Grupo Colaborativo de Unidades de Seguimiento en España [Treatment and follow-up of patients with phenylketonuria: Results from the Collaborative Group of Spanish Follow-up Units]. Medicina Clínica, 138(5), 185–191. doi:10.1016/j.medcli.2011.03.037
   PubMed Web of Science ®Google Scholar
• Channon, S., German, E., Cassina, C., & Lee, P. (2004). Executive functioning, memory, and learning in Phenylketonuria. Neuropsychology, 18(4), 613–620. doi:10.1037/0894-4105.18.4.613
   PubMed Web of Science ®Google Scholar
• Channon, S., Goodman, G., Zlotowitz, S., Mockler, C., & Lee, P. J. (2007). Effects of dietary management of phenylketonuria on long-term cognitive outcome. Archives of Disease in Childhood, 92(3), 213–218. doi:10.1136/adc.2006.104786
   PubMed Web of Science ®Google Scholar
• Cleary, M. A., Walter, J. H., Wraith, J. E., White, F., Tyler, K., & Jenkins, J. P. (1995). Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change. The Journal of Pediatrics, 127(2), 251–255. doi:10.1016/S0022-3476(95)70303-9
   PubMed Web of Science ®Google Scholar
• Cook, D. J. (1997). Systematic reviews: Synthesis of best evidence for clinical decisions. Annals of Internal Medicine, 126(5), 376. doi:10.7326/0003-4819-126-5-199703010-00006
   PubMed Web of Science ®Google Scholar
• Crowley, C., Koch, R., Fishler, K., Wenz, E., & Ireland, J. (1990). Clinical trial of “off diet” older phenylketonurics with a new phenylalanine-free product. Journal of Intellectual Disability Research, 34(4), 361–369. doi:10.1111/j.1365-2788.1990.tb01546.x
   Google Scholar
• Dawson, C., Murphy, E., Maritz, C., Chan, H., Ellerton, C., Carpenter, R. H. S., & Lachmann, R. H. (2011). Dietary treatment of phenylketonuria: The effect of phenylalanine on reaction time. Journal of Inherited Metabolic Disease, 34(2), 449–454. doi:10.1007/s10545-010-9276-2
   PubMed Web of Science ®Google Scholar
• Dechartres, A., Boutron, I., Trinquart, L., Charles, P., & Ravaud, P. (2011). Single-center trials show larger treatment effects than Multicenter trials: Evidence from a Meta-epidemiologic study. Annals of Internal Medicine, 155(1), 39. doi:10.7326/0003-4819-155-1-201107050-00006
   PubMed Web of Science ®Google Scholar
• de Groot, M. J., Hoeksma, M., Reijngoud, D.-J., de Valk, H. W., Paans, A. M., Sauer, P. J., & van Spronsen, F. J. (2013). Phenylketonuria: Reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet Journal of Rare Diseases, 8(1), 133. doi:10.1186/1750-1172-8-133
   PubMed Web of Science ®Google Scholar
• DeRoche, K., & Welsh, M. (2008). Twenty-Five years of research on Neurocognitive outcomes in early-treated Phenylketonuria: Intelligence and executive function. Developmental Neuropsychology, 33(4), 474–504. doi:10.1080/87565640802101482
   PubMed Web of Science ®Google Scholar
• DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188. doi:10.1016/0197-2456(86)90046-2
   PubMedGoogle Scholar
• Dyer, C. A. (1999). Pathophysiology of phenylketonuria. Mental Retardation and Developmental Disabilities Research Reviews, 5(2), 104–112. doi:10.1002/(sici)1098-2779(1999)5:2<104::aid-mrdd2>3.0.co;2-7
   Google Scholar
• Feldmann, R., Denecke, J., Grenzebach, M., & Weglage, J. (2005). Frontal lobe-dependent functions in treated phenylketonuria: Blood phenylalanine concentrations and long-term deficits in adolescents young adults. Journal of Inherited Metabolic Disease, 28(4), 445–455. doi:10.1007/s10545-005-0445-7
   PubMed Web of Science ®Google Scholar
• Finkelson, L., Bailey, I., & Waisbren, S. E. (2001). Short report: PKU adults and their return to diet: Predicting diet continuation and maintenance. Journal of Inherited Metabolic Disease, 24(4), 515–516. doi:10.1023/a:1010546000617
   PubMed Web of Science ®Google Scholar
• Fisch, R. O., Chang, P., Weisberg, S., Guldberg, P., Güttler, F., & Tsai, M. Y. (1995). Phenylketonuric patients decades after diet. Journal of Inherited Metabolic Disease, 18(3), 347–353. doi:10.1007/bf00710427
   PubMed Web of Science ®Google Scholar
• Fitzgerald, B., Morgan, J., Keene, N., Rollinson, R., Hodgson, A., & Dalrymple-Smith, J. (2000). An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability. Journal of Intellectual Disability Research, 44(1), 53–59. doi:10.1046/j.1365-2788.2000.00260.x
   PubMed Web of Science ®Google Scholar
• Freeman, M. F., & Tukey, J. W. (1950). Transformations related to the angular and the square root. The Annals of Mathematical Statistics, 21(4), 607–611. doi:10.1214/aoms/1177729756
   Google Scholar
• Gassió, R., Campistol, J., Vilaseca, M., Lambruschini, N., Cambra, F., & Fusté, E. (2003). Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatrica, 92(12), 1474–1478. doi:10.1111/j.1651-2227.2003.tb00834.x
   PubMed Web of Science ®Google Scholar
• Gentile, J. K., ten Hoedt, A. E., & Bosch, A. M. (2010). Psychosocial aspects of PKU: Hidden disabilities – A review☆. Molecular Genetics and Metabolism, 99, S64–S67. doi:10.1016/j.ymgme.2009.10.183
   Google Scholar
• González, M. J., Gutiérrez, A. P., Gassió, R., Fusté, M. E., Vilaseca, M. A., & Campistol, J. (2011). Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Molecular Genetics and Metabolism, 104, S73–S79. doi:10.1016/j.ymgme.2011.07.015
   Google Scholar
• Griffiths, P., Paterson, L., & Harvie, A. (1995). Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with eariy-treated phenylketonuria. Journal of Intellectual Disability Research, 39(5), 365–372. doi:10.1111/j.1365-2788.1995.tb00540.x
   PubMed Web of Science ®Google Scholar
• Hedges, L. V. (1981). Distribution theory for Glass’s estimator of effect size and related estimators. Journal of Educational and Behavioral Statistics, 6(2), 107–128. doi:10.3102/10769986006002107
   Google Scholar
• Higgins, J. P. T., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Hoeksma, M., Reijngoud, D.-J., Pruim, J., de Valk, H. W., Paans, A. M. J., & van Spronsen, F. J. (2009). Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis. Molecular Genetics and Metabolism, 96(4), 177–182. doi:10.1016/j.ymgme.2008.12.019
   PubMed Web of Science ®Google Scholar
• Huttenlocher, P. R. (2000). The neuropathology of phenylketonuria: Human and animal studies. European Journal of Pediatrics, 159(S2), S102–S106. doi:10.1007/pl00014371
   Google Scholar
• Kalkanoğlu, H. S., Ahring, K. K., Sertkaya, D., Birk Møller, L., Romstad, A., Mikkelsen, I., … Güttler, F. (2005). Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria. Acta Paediatrica, 94(9), 1218–1222. doi:10.1111/j.1651-2227.2005.tb02078.x
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-Month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. doi:10.1001/archpsyc.62.6.617
   PubMed Web of Science ®Google Scholar
• Koch, R., Burton, B., Hoganson, G., Peterson, R., Rhead, W., Rouse, B., … Azen, C. (2002). Phenylketonuria in adulthood: A collaborative study. Journal of Inherited Metabolic Disease, 25(5), 333–346. doi:10.1023/a:1020158631102
   PubMed Web of Science ®Google Scholar
• Kreis, R., Zwygart, K., Boesch, C., & Nuoffer, J.-M. (2009). Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1 H-MR spectroscopy. Magnetic Resonance in Medicine, 62(1), 11–16. doi:10.1002/mrm.21983
   PubMed Web of Science ®Google Scholar
• Landvogt, C., Mengel, E., Bartenstein, P., Buchholz, H. G., Schreckenberger, M., Siessmeier, T., … Ullrich, K. (2008). Reduced cerebral fluoro-l-dopamine uptake in adult patients suffering from phenylketonuria. Journal of Cerebral Blood Flow & Metabolism, 28(4), 824–831. doi:10.1038/sj.jcbfm.9600571
   PubMed Web of Science ®Google Scholar
• Lee, P. J., Amos, A., Robertson, L., Fitzgerald, B., Hoskin, R., Lilburn, M., … Murphy, G. (2009). Adults with late diagnosed PKU and severe challenging behaviour: A randomised placebo-controlled trial of a phenylalanine-restricted diet. Journal of Neurology, Neurosurgery & Psychiatry, 80(6), 631–635. doi:10.1136/jnnp.2008.151175
   PubMed Web of Science ®Google Scholar
• Leuzzi, V., Bianchi, M. C., Tosetti, M., Carducci, C., & Antonozzi, I. (2000). Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. Journal of Inherited Metabolic Disease, 23(6), 563–570. doi:10.1023/a:1005621727560
   PubMed Web of Science ®Google Scholar
• Leuzzi, V., Tosetti, M., Montanaro, D., Carducci, C., Artiola, C., Antonozzi, I., … Scarabino, T. (2007). The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 Tesla MRI and magnetic resonance spectroscopy (1H MRS) study. Journal of Inherited Metabolic Disease, 30(2), 209–216. doi:10.1007/s10545-006-0399-4
   PubMed Web of Science ®Google Scholar
• Leuzzi, V., Trasimeni, G., Gualdi, G. F., & Antonozzi, I. (1995). Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients. Journal of Inherited Metabolic Disease, 18(5), 624–634. doi:10.1007/bf02436009
   PubMed Web of Science ®Google Scholar
• Lindegren, M. L., Krishnaswami, S., Fonnesbeck, C., Reimschisel, T., Fisher, J., Jackson, K., … McPheeters, M. L. (2012). Adjuvant Treatment for Phenylketonuria (PKU). Comparative Effectiveness Review No. 56. AHRQ Publication No. 12-EHC035-EF. Rockville, MD.
   Google Scholar
• Lou, H. C., Lykkelund, C., Gerdes, A., Udesen, H., & Bruhn, P. (1987). Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatrica, 76(4), 560–565. doi:10.1111/j.1651-2227.1987.tb10521.x
   PubMed Web of Science ®Google Scholar
• Luciana, M., Hanson, K., & Whitley, C. (2004). A preliminary report on dopamine system reactivity in PKU: Acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions. Psychopharmacology, 175(1), 18–25. doi:10.1007/s00213-004-1775-0
   PubMed Web of Science ®Google Scholar
• Luciana, M., Sullivan, J., & Nelson, C. A. (2001). Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child Development, 72(6), 1637–1652. doi:10.1111/1467-8624.00370
   PubMed Web of Science ®Google Scholar
• Marholin, D., Pohl, R. E., Stewart, R. M., Touchette, P. E., Townsend, N. M., & Kolodny, E. H. (1978). Effects of diet and behavior therapy on social and motor behavior of retarded Phenylketonuric adults: An experimental analysis. Pediatric Research, 12(3), 179–187. doi:10.1203/00006450-197803000-00004
   PubMed Web of Science ®Google Scholar
• McAuley, T., & White, D. A. (2011). A latent variables examination of processing speed, response inhibition, and working memory during typical development. Journal of Experimental Child Psychology, 108(3), 453–468. doi:10.1016/j.jecp.2010.08.009
   PubMed Web of Science ®Google Scholar
• McDonnell, G. V., Esmonde, T. F., Hadden, D. R., & Morrow, J. I. (1998). A neurological evaluation of adult phenylketonuria in Northern Ireland. European Neurology, 39(1), 38–43. doi:10.1159/000007895
   PubMed Web of Science ®Google Scholar
• Moyle, J. J., Fox, A. M., Arthur, M., Bynevelt, M., & Burnett, J. R. (2007). Meta-Analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychology Review, 17(2), 91–101. doi:10.1007/s11065-007-9021-2
   PubMed Web of Science ®Google Scholar
• Moyle, J. J., Fox, A. M., Bynevelt, M., Arthur, M., & Burnett, J. R. (2006). Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuria. Clinical Neurophysiology, 117(10), 2154–2160. doi:10.1016/j.clinph.2006.05.027
   PubMed Web of Science ®Google Scholar
• Moyle, J. J., Fox, A. M., Bynevelt, M., Arthur, M., & Burnett, J. R. (2007). A neuropsychological profile of off-diet adults with phenylketonuria. Journal of Clinical and Experimental Neuropsychology, 29(4), 436–441. doi:10.1080/13803390600745829
   PubMed Web of Science ®Google Scholar
• Mulrow, C. D., & Oxman, A. D. (1997). Cochrane collaboration handbook (The Cochrane Collaboration Issue (1st ed.). Oxford, UK: Cochrane Library.
   Google Scholar
• National Institutes of Health Consensus Development Conference Statement: Phenylketonuria: Screening and management, October 16–18, 2000. (2001). Pediatrics, 108(4), 972–982. doi:10.1542/peds.108.4.972
   PubMed Web of Science ®Google Scholar
• Pardridge, W. M., & Choi, T. B. (1986). Neutral amino acid transport at the human blood-brain barrier. Federation Proceedings, 45(7), 2073–2078.
   PubMedGoogle Scholar
• Pfaendner, N. H., Reuner, G., Pietz, J., Jost, G., Magnotta, V. A., Mohr, A., & Hähnel, S. (2005). MR imaging-based volumetry in patients with early-treated phenylketonuria. American Journal of Neuroradiology, 26(7), 1681–1685.
   PubMed Web of Science ®Google Scholar
• Phillips, M. D., McGraw, P., Lowe, M. J., Mathews, V. P., & Hainline, B. E. (2001). Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. American Journal of Neuroradiology, 22(8), 1583–1586.
   PubMed Web of Science ®Google Scholar
• Pietz, J., Dunckelmann, R., Rupp, A., Rating, D., Meinck, H., Schmidt, H., & Bremer, H. J. (1998). Neurological outcome in adult patients with early-treated phenylketonuria. European Journal of Pediatrics, 157(10), 824–830. doi:10.1007/s004310050945
   PubMed Web of Science ®Google Scholar
• Pietz, J., Fatkenheuer, B., Armbruster, M., Esser, G., & Schmidt, H. (1997). Psychiatric disorders in adult patients with early-treated Phenylketonuria. Pediatrics, 99(3), 345–350. doi:10.1542/peds.99.3.345
   PubMed Web of Science ®Google Scholar
• Pietz, J., Landwehr, R., Kutscha, A., Schmidt, H., de Sonneville, L., & Trefz, F. K. (1995). Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria. The Journal of Pediatrics, 127(6), 936–943. doi:10.1016/s0022-3476(95)70031-5
   PubMed Web of Science ®Google Scholar
• Pietz, J., Schmidt, E., Matthis, P., Kobialka, B., Kutscha, A., & Sonneville, L. (1993). EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function. Developmental Medicine & Child Neurology, 35(1), 54–64. doi:10.1111/j.1469-8749.1993.tb11552.x
   PubMed Web of Science ®Google Scholar
• Pitt, D. B., & Danks, D. M. (1991). The natural history of untreated phenylketonuria over 20 years. Journal of Paediatrics and Child Health, 27(3), 189–190. doi:10.1111/j.1440-1754.1991.tb00384.x
   PubMed Web of Science ®Google Scholar
• Ris, M. D., Weber, A. M., Hunt, M. M., Berry, H. K., Williams, S. E., & Leslie, N. (1997). Adult psychosocial outcome in early-treated phenylketonuria. Journal of Inherited Metabolic Disease, 20(4), 499–508. doi:10.1023/A:1005389110739
   PubMed Web of Science ®Google Scholar
• Rosenthal, R. (1979). The file drawer problem and tolerance for null results. Psychological Bulletin, 86(3), 638–641. doi:10.1037/0033-2909.86.3.638
   Web of Science ®Google Scholar
• Rupp, A., Kreis, R., Zschocke, J., Slotboom, J., Boesch, C., Rating, D., & Pietz, J. (2001). Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. Journal of Cerebral Blood Flow & Metabolism, 21(3), 276–284. doi:10.1097/00004647-200103000-00011
   PubMed Web of Science ®Google Scholar
• Santos, L. L., Fonseca, C. G., Starling, A. L. P., Januario, J. N., Aguiar, M. J. B., Peixoto, M. G. C. D., & Carvalho, M. R. S. (2010). Variations in genotype-phenotype correlations in phenylketonuria patients. Genetics and Molecular Research, 9(1), 1–8. doi:10.4238/vol9-1gmr670
   PubMed Web of Science ®Google Scholar
• Scarabino, T., Popolizio, T., Tosetti, M., Montanaro, D., Giannatempo, G. M., Terlizzi, R., … Salvolini, U. (2009). Phenylketonuria: White-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. La Radiologia Medica, 114(3), 461–474. doi:10.1007/s11547-009-0365-y
   PubMed Web of Science ®Google Scholar
• Schmidt, E., Rupp, A., Burgard, P., Pietz, J., Weglage, J., & Sonneville, L. D. (1994). Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level. Journal of Clinical and Experimental Neuropsychology, 16(5), 681–688. doi:10.1080/01688639408402681
   PubMed Web of Science ®Google Scholar
• Schuett, V. E., Brown, E. S., & Michals, K. (1985). Reinstitution of diet therapy in PKU patients from twenty-two US clinics. American Journal of Public Health, 75(1), 39–42. doi:10.2105/ajph.75.1.39
   PubMed Web of Science ®Google Scholar
• Stahl, S. M. (2000). Essential psychopharmacology neuroscientific basis and practical applications (2nd ed.). New York, NY: Cambridge University Press.
   Google Scholar
• Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA, 283(15), 2008–2012. doi:10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Sundermann, B., Pfleiderer, B., Möller, H. E., Schwindt, W., Weglage, J., Lepsien, J., & Feldmann, R. (2011). Tackling frontal lobe–related functions in PKU through functional brain imaging: A Stroop task in adult patients. Journal of Inherited Metabolic Disease, 34(3), 711–721. doi:10.1007/s10545-011-9318-4
   PubMed Web of Science ®Google Scholar
• ten Hoedt, A. E., de Sonneville, L. M. J., Francois, B., Ter Horst, N. M., Janssen, M. C. H., Rubio-Gozalbo, M. E., … Bosch, A. M. (2011). High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: A randomised, double-blind, placebo-controlled, crossover trial. Journal of Inherited Metabolic Disease, 34(1), 165–171. doi:10.1007/s10545-010-9253-9
   PubMed Web of Science ®Google Scholar
• Thompson, A. J., Tillotson, S., Smith, I., Kendall, B., Moore, S. G., & Brenton, D. P. (1993). Brain MRI changes in phenylketonuria: Associations with dietary status. Brain, 116(4), 811–821. doi:10.1093/brain/116.4.811
   PubMed Web of Science ®Google Scholar
• Ullrich, K., Weglage, J., Pietsch, M., Fünders, B., Oberwittler, C., Von Eckardstein, H., & Colombo, J. P. (1996). Effect of L-DOPA on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. European Journal of Pediatrics, 155(S1), S74–S77. doi:10.1007/pl00014256
   Google Scholar
• Vockley, J., Andersson, H. C., Antshel, K. M., Braverman, N. E., Burton, B. K., Frazier, D. M., … Berry, S. A. (2014). Phenylalanine hydroxylase deficiency: Diagnosis and management guideline. Genetics in Medicine, 16(2), 188–200. doi:10.1038/gim.2013.157
   PubMed Web of Science ®Google Scholar
• Waisbren, S. E., Noel, K., Fahrbach, K., Cella, C., Frame, D., Dorenbaum, A., & Levy, H. (2007). Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis. Molecular Genetics and Metabolism, 92(1–2), 63–70. doi:10.1016/j.ymgme.2007.05.006
   PubMed Web of Science ®Google Scholar
• Wasserstein, M. P., Snyderman, S. E., Sansaricq, C., & Buchsbaum, M. S. (2006). Cerebral glucose metabolism in adults with early treated classic phenylketonuria. Molecular Genetics and Metabolism, 87(3), 272–277. doi:10.1016/j.ymgme.2005.06.010
   PubMed Web of Science ®Google Scholar
• Welch, V., Petticrew, M., Tugwell, P., Moher, D., O’Neill, J., Waters, E., & White, H. (2012). PRISMA-Equity 2012 extension: Reporting guidelines for systematic reviews with a focus on health equity. Revista Panamericana de Salud Pública, 34(1), 60–67. doi:10.1371/journal.pmed.1001333
   Web of Science ®Google Scholar
• Yannicelli, S., & Ryan, A. (1995). Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: A national survey. Journal of Inherited Metabolic Disease, 18(2), 131–134. doi:10.1007/bf00711747
   PubMed Web of Science ®Google Scholar